Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients
Clinical trial NCT05409612 · COMPLETED
Trial details
- NCT number
- NCT05409612
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2023-04-20
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.